Leading clinical data analytics platform firm Saama Technologies, Inc., closed a $40 million financing round led by Perceptive Advisors. Torreya Partners served as financial advisor to Saama in conjunction with this transaction, which brings the total raised since 2015 to $75 million.
The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform addressing the planning, designing and conduct of clinical trials across various stages of clinical development. LSAC is designed to ingest, integrate, curate, and harmonize clinical trial operational and patient data from proprietary and external data sources to deliver actionable, regulatory-ready insights. Its deep learning approach compresses clinical program timelines from clinical plan development to submission judgment for a new drug application.